Incorporation of phosphatidylserine improves efficiency of lipid based gene delivery systems.
Lipid composition
Lipid nanoparticles
Nucleic acid delivery
Phosphatidylserine
Transfection efficiency
Transfection potency
Journal
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
05
11
2021
revised:
11
02
2022
accepted:
11
02
2022
pubmed:
20
2
2022
medline:
5
4
2022
entrez:
19
2
2022
Statut:
ppublish
Résumé
The essential homeostatic process of dead cell clearance (efferocytosis) is used by viruses in an act of apoptotic mimicry. Among others, virions leverage phosphatidylserine (PS) as an essential "eat me" signal in viral envelopes to increase their infectivity. In a virus-inspired biomimetic approach, we demonstrate that PS can be incorporated into non-viral lipid nanoparticle (LNP) pDNA/mRNA constructs to enhance cellular transfection. The inclusion of the bioactive PS leads to an increased ability of LNPs to deliver nucleic acids in vitro to cultured HuH-7 hepatocellular carcinoma cells resulting in a 6-fold enhanced expression of a transgene. Optimal PS concentrations are in the range of 2.5 to 5% of total lipids. PS-decorated mRNA-LNPs show a 5.2-fold enhancement of in vivo transfection efficiency as compared to mRNA-LNPs devoid of PS. Effects were less pronounced for PS-decorated pDNA-LNPs (3.2-fold increase). Incorporation of small, defined amounts of PS into gene delivery vectors opens new avenues for efficient gene therapy and can be easily extended to other therapeutic systems.
Identifiants
pubmed: 35181492
pii: S0939-6411(22)00028-5
doi: 10.1016/j.ejpb.2022.02.007
pii:
doi:
Substances chimiques
Lipid Nanoparticles
0
Liposomes
0
Phosphatidylserines
0
RNA, Messenger
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
134-143Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.